![Shawn O'Brien](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shawn O'Brien
Vorstandsvorsitzender bei
SFA Therapeutics, Inc.
Vermögen: 481 211 $ am 31.07.2026
Profil
Mr. Shawn P.
O'Brien is a Chairman at Alto Pharmaceuticals Ltd. and a Chairman & Chief Executive Officer at SFA Therapeutics, Inc. Mr. O'Brien was previously employed as a Chief Executive Officer, Director & MD by Mayne Pharma Group Ltd., a Chief Executive Officer & Director by Genomind, Inc., a President by Cipher Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by AltheRx, Inc., a President, Chief Executive Officer & Director by Profectus BioSciences, Inc., a President, Chief Executive Officer & Director by Solstice Neurosciences, Inc., a Vice President-Commercial Operations by AstraZeneca Pharmaceuticals LP, and a Principal by The Upjohn Co. He also served on the board at Melanovus Oncology, Inc., Crozer-Keystone Health System and Cyrano LLC.
He received his undergraduate degree from the University of Western Ontario.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MAYNE PHARMA GROUP LTD. 0,32 % | 20.02.2026 | 257 573 ( 0,32 % ) | 481 211 $ | 31.07.2026 |
Aktive Positionen von Shawn O'Brien
| Unternehmen | Position | Beginn |
|---|---|---|
Alto Pharmaceuticals Ltd.
 Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products | Vorsitzender | - |
SFA Therapeutics, Inc.
 SFA Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a platform that provides treatment services for chronic diseases | Vorstandsvorsitzender | 19.08.2026 |
Ehemalige bekannte Positionen von Shawn O'Brien
| Unternehmen | Position | Ende |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Vorstandsvorsitzender | 20.02.2026 |
| CIPHER PHARMACEUTICALS INC. | Vorstandsvorsitzender | 11.11.2016 |
Crozer-Keystone Health System
 Crozer-Keystone Health System Medical/Nursing ServicesHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | 01.06.2016 |
Melanovus Oncology, Inc.
 Melanovus Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing services | Direktor/Vorstandsmitglied | 01.12.2014 |
Altherx, Inc.
 Altherx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers clinical development for overactive bladder and irritable bowel syndrome | Gründer | 01.02.2013 |
Ausbildung von Shawn O'Brien
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
49
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Solstice Neurosciences, Inc.
 Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, sells and markets biopharmaceutical products | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crozer-Keystone Health System
Crozer-Keystone Health System Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops preventive and therapeutic vaccines | Health Technology |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Mayne Pharma Group Ltd.
 Mayne Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which develops and manufactures proprietary and generic products | Health Technology |
Altherx, Inc.
Altherx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers clinical development for overactive bladder and irritable bowel syndrome | Commercial Services |
Genomind, Inc.
 Genomind, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
Melanovus Oncology, Inc.
Melanovus Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing services | Commercial Services |
Alto Pharmaceuticals Ltd.
Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products | Health Technology |
SFA Therapeutics, Inc.
SFA Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a platform that provides treatment services for chronic diseases | Technology Services |
Cyrano LLC |
